MedPath

神威药业（四川）有限公司

Ownership
-
Established
2003-09-15
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

27

NMPA:27

Drug Approvals

参七心疏片

Approval Number
国药准字Z20090624
Approval Date
Jun 15, 2023
NMPA

四物片

Approval Number
国药准字Z20080090
Approval Date
Mar 1, 2023
NMPA

银黄注射液

Approval Number
国药准字Z20064389
Approval Date
Sep 28, 2022
NMPA

香丹注射液

Approval Number
国药准字Z13020941
Approval Date
Feb 23, 2021
NMPA

Compound Aminophenazone and Barbital Injection

Product Name
复方氨林巴比妥注射液
Approval Number
国药准字H13024488
Approval Date
Feb 3, 2021
NMPA

鱼腥草注射液

Approval Number
国药准字Z20044484
Approval Date
Nov 17, 2020
NMPA

鱼腥草注射液

Approval Number
国药准字Z20044282
Approval Date
Nov 17, 2020
NMPA

鹿茸精注射液

Approval Number
国药准字Z20053092
Approval Date
Nov 17, 2020
NMPA

丁公藤注射液

Approval Number
国药准字Z20044393
Approval Date
Nov 17, 2020
NMPA

柴辛感冒注射液

Approval Number
国药准字Z20026667
Approval Date
Nov 17, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.